scispace - formally typeset
Open AccessJournal ArticleDOI

Acute and chronic arsenic toxicity

Ranjit N. Ratnaike
- 01 Jul 2003 - 
- Vol. 79, Iss: 933, pp 391-396
Reads0
Chats0
TLDR
There are no evidence based treatment regimens to treat chronic arsenic poisoning but antioxidants have been advocated, though benefit is not proven, and there is increasing emphasis on using alternative supplies of water.
Abstract
Arsenic toxicity is a global health problem affecting many millions of people. Contamination is caused by arsenic from natural geological sources leaching into aquifers, contaminating drinking water and may also occur from mining and other industrial processes. Arsenic is present as a contaminant in many traditional remedies. Arsenic trioxide is now used to treat acute promyelocytic leukaemia. Absorption occurs predominantly from ingestion from the small intestine, though minimal absorption occurs from skin contact and inhalation. Arsenic exerts its toxicity by inactivating up to 200 enzymes, especially those involved in cellular energy pathways and DNA synthesis and repair. Acute arsenic poisoning is associated initially with nausea, vomiting, abdominal pain, and severe diarrhoea. Encephalopathy and peripheral neuropathy are reported. Chronic arsenic toxicity results in multisystem disease. Arsenic is a well documented human carcinogen affecting numerous organs. There are no evidence based treatment regimens to treat chronic arsenic poisoning but antioxidants have been advocated, though benefit is not proven. The focus of management is to reduce arsenic ingestion from drinking water and there is increasing emphasis on using alternative supplies of water.

read more

Citations
More filters
Journal ArticleDOI

Torsades de Pointes precoces y elevación sérica de la troponina I debidas a intoxicación aguda por arsénico

TL;DR: Se describe un caso de intoxicacion aguda por arsenico que tuvo torsades de Pointes precoces, hipopotasemia y altos niveles sericos de troponina I.

Metals and Metalloids

TL;DR: A systematic review of the literature and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990 Behavioral, environmental for the Global Burden of Disease found very low lead exposures and children’s neurodevelopment.
Journal ArticleDOI

Initial Assessment of Variability of Responses to Toxicants in Donor-Specific Endothelial Colony Forming Cells.

TL;DR: The statistical analysis used to compare the entire concentration-effect curves has revealed significant differences in levels of cytotoxicity induced by the toxic and relatively nontoxic chemical counterparts, demonstrating that donor-specific ECFCs can clearly differentiate between these two groups of chemicals.
Journal ArticleDOI

Protective effect of Mucuna pruriens against arsenic-induced liver and kidney dysfunction and neurobehavioral alterations in rats

TL;DR: Serum ALT, serum urea, and serum creatinine levels showed significant improvement on long-term treatment with M. pruriens, and the number of surviving neurons in the CA1 and CA3 regions also increased on treatment with the seed extract.
Journal ArticleDOI

Characterisation of non-exhaust emissions from road traffic in Lisbon

TL;DR: In this article , the thoracic fraction of road dust (PM 10 ) by collecting samples directly from road pavements by an in situ resuspension chamber was characterized, taking into account the carbonaceous content and the sum of the elements in their oxidized form.
References
More filters
Journal ArticleDOI

Molecular characterization of mitochondrial apoptosis-inducing factor

TL;DR: The identification and cloning of an apoptosis-inducing factor, AIF, which is sufficient to induce apoptosis of isolated nuclei is reported, indicating that AIF is a mitochondrial effector of apoptotic cell death.
Journal ArticleDOI

Arsenic poisoning of Bangladesh groundwater

TL;DR: Sedimentological study of the Ganges alluvial sediments shows that the arsenic derives from the reductive dissolution of arsenic-rich iron oxyhydroxides, which in turn are derived from weathering of base-metal sulphides.
Journal ArticleDOI

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

TL;DR: As2O3 treatment is an effective and relatively safe drug in APL patients refractory to ATRA and conventional chemotherapy, and Pharmacokinetic studies showed that after a peak level of 5.54 micromol/L, plasma arsenic was rapidly eliminated, and the continuous administration of As2O2 did not alter its pharmacokinetic behaviors.
Journal ArticleDOI

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

TL;DR: Low doses of arsenic trioxide can induce complete remissions in patients with APL who have relapsed and the clinical response is associated with incomplete cytodifferentiation and the induction of apoptosis with caspase activation in leukemic cells.
Journal ArticleDOI

Arsenic in the geosphere - a review.

TL;DR: An attempt is made to quantify the global element cycle for arsenic, based on an extensive literature research with special emphasis on the most recent works.
Related Papers (5)
Trending Questions (1)
Toxic properties of Arsenic trichloride?

The provided paper does not mention the specific toxic properties of Arsenic trichloride.